GlassScriptPhysician profile
Mariam Khandaker
NPI 1104289545
$5,123.23
in general payments reported to CMS, 2019-2025
21 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $44.77 · 2021: $120 · 2022: $1,518 · 2023: $1,445 · 2024: $651 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,607 · Travel and Lodging: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,607.29 |
| Travel and Lodging | $651.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $827.06 | 2019-2023 | Cardiomems |
| Shockwave Medical, INC | $819.93 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $752.26 | 2022-2025 | Sync, Igt Devices Undivided, Coronary Other |
| Bard Peripheral Vascular, INC. | $628.99 | 2024-2025 | Venovo |
| Medtronic, INC. | $474.34 | 2021-2025 | Corevalve Evolut R, Venaseal |
| Surmodics, INC. | $411.46 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Boston Scientific Corporation | $209.51 | 2023 | Rotapro |
| Abiomed | $161.02 | 2023 | Impella |
| Terumo Medical Corporation | $150.00 | 2025 | Metacross Otw, Glidewire, Optitorque |
| Chiesi USA, INC. | $127.73 | 2023 | Kengreal |
| E.R. Squibb & Sons, L.L.C. | $113.22 | 2022-2023 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.30 | 2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $62.58 | 2025 | |
| Cardiovascular Systems INC. | $55.96 | 2022 | |
| Cagent Vascular INC | $48.59 | 2023 | Serrantor |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akcea Therapeutics, INC. | $44.77 | 2020 | |
| Amgen INC. | $35.78 | 2022-2023 | Repatha |
| Pfizer INC. | $26.17 | 2024 | |
| Lantheus Medical Imaging, INC. | $25.85 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.95 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $16.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariam Khandaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.